EDMONTON, AB, April 10 /CNW/ - BioMS Medical Corp (TSX: MS), a leading developer of products for the treatment of multiple sclerosis (MS), today announced it has filed a preliminary short form prospectus with securities regulatory authorities in British Columbia, Alberta, Manitoba, Ontario and Québec in connection with a public offering of common shares of the Company.
